Dr. Ramesh Paladugu, MD

Dr. Paladugu practices at Vascular and Vein Center PA in Fort Worth, Texas.

Dr. Paladugu's NPI, 1548354921, was assigned on October 3, 2006. Dr. Paladugu graduated from Kurnool Medical College in 1988. Dr. Paladugu holds Texas license L9584.

Dr. Paladugu's primary practice is Vascular and Vein Center PA, at 851 W Terrell Ave, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 332-8346.

Dr. Paladugu's primary practice is Vascular and Vein Center PA in Fort Worth, Texas. Dr. Paladugu is also affiliated with Texas Health Fort Worth. The medical group on file is Texas Vascular and Vein Center. Dmand AI also links Dr. Paladugu to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paladugu practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Paladugu's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Paladugu is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Paladugu's licenses on file in 2 states: Texas and New Mexico.

Dmand AI lists aortic atherosclerois, chronic skin ulcer, circulatory problems in extremities, leg revascularization, lymphedema, peripheral vascular disease and varicose veins among the conditions Dr. Paladugu treats.

CMS data shows 1,458 Medicare services from Dr. Paladugu across 25 procedure codes in 2024, for 410 Medicare patients. Medicare paid $413,817 for them.

CMS counts 410 Medicare patients who saw Dr. Paladugu in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Paladugu's median patient age at 71, with 52% women.

In 2024, Dr. Paladugu wrote 690 Medicare Part D claims for 266 patients. 83% of them were for generic drugs. CMS names the drug for 669 of them, across 9 drugs with 11 or more claims each, at $165,940 in total drug cost. In 2023, CMS named 526 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Paladugu for performance year 2024, reported as part of a group. Dr. Paladugu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Paladugu as offering telehealth. CMS counts 71 procedures of leg revascularization (restoring blood flow) by Dr. Paladugu, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Paladugu in 2002. The most frequent topics are Coronary Vessels, Endothelium, Vascular and Models, Animal. Dr. Paladugu has published most often in Am J Surg. Dr. Paladugu's most frequent co-authors are Peter H. Lin, MD, Alan B. Lumsden, MD and Ruth L. Bush, MD.

CMS Open Payments shows 243 general payments to Dr. Paladugu from 42 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 37% of the total. Boston Scientific Corporation paid the most, $8,791.

Dmand AI lists 2 awards for Dr. Paladugu, most recently ACS Fellow in 2013.

Dr. Paladugu graduated from Kurnool Medical College in 1988. Dr. Paladugu is a member of ACS and SVS.

Dr. Paladugu is in network with 23 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.